RESOURCES

Blogs

Insight at the intersection of data science and real-world health

The Talking Room

Demystifying AI, LLMs and machine learning

Use Cases

How teams put the signals to work

Compliance Hub

Data integrity, ethical AI and regulatory standards

DrugVoice

Built to be defensible.

Compliance, ethics, and data integrity are part of the process.

TMLABS

About us

Where our proprietary models are trained, tested and refined

Articles & scientific publications

Peer-reviewed methodologies and validated outcomes

Latest paper

The New GLP-1 Consumer

Articles & Scientific Publications

DRUGVOICE

DrugVoice

Measure how your messaging lands and evidence what moved

SEE IT IN ACTION

Bring us a question you can’t answer.

We’ll show you what the conversation already contains, using your therapy area and your audience.

ABOUT US

About us

Where our proprietary models are trained, tested and refined

ESG

Responsible innovation and ethical data practice

WHO WE ARE

Data scientists who speak pharma.

A team built around one problem: making real-world conversation usable at scale.

Optimizing Rare Disease Communication with DrugVoice
Download

At a Glance

Challenges

  • Impact measurement difficulties: Struggled to accurately assess the effectiveness of educational materials across multiple data sources
  • Varied data sources: Faced challenges in synthesizing insights from varied sources like surveys and educational content
  • Lack of comprehensive analytics: Limited ability to gauge overall engagement and the real-world impact of Patient education efforts

Benefits

  • Enhanced efficiency: Achieved an 80% increase in intelligence generation, enabling quicker analysis of educational material impact
  • Deeper Patient insights: Provided longitudinal understanding of Patient alignment with key messages and tracked shifts in conversation trends and agree levels
  • Improved Content Optimization: Identified areas for improvement, allowing for the continuous refinement of educational materials for better future engagement

Customer Objective

Healthcare Advertising Agency G struggled to understand and measure the impact and effectiveness of educational materials that had been generated by their Client surrounding HER1+ Breast Cancer using social data and survey data from Patient Interviews.

Brief

The Agency wanted an accurate way to quantify the alignment of Patients speaking in various data sources with key brand messaging from educational content. They wanted to be be able to track changes in alignment over time as a key performance indicator (KPI) and identify key brand messages written by Patients that have lower levels of alignment with these key brand messages.

Solution

This AI-assisted approach led to:

  • An 80% improvement in efficiency
  • Longitudinal insights generation
  • The processing of more data from diverse sources
  • A better understanding of Patient alignment with key brand messages

This allowed the Agency to effectively monitor the impact of
their educational material on Patient conversations and
alignment levels as well as identify areas for improvement for
optimization of future material.

Contact Britt Gibson, Manager Global Customer Engagement, at britt@talkingmedicines.com.

Read More

#
$